ADC Outsourcing Is Now A Global Strategy

This segment of the Outsourced Pharma Live event, “ADC Outsourcing: Plan Smart Now Or Suffer Later,” examines how the ADC outsourcing environment has shifted as innovation has become more global, early clinical work increasingly includes regions such as China, and sponsors must think more carefully about CDMO network design. Reza also breaks down where capacity has expanded, including monoclonal antibody production, and where pressure remains tight, especially in bioconjugation and cytotoxic fill-finish. Featuring Reza Oliyai, Ph.D., President and CEO, Oliyai Consulting Corporation.